Digitisation | May 24, 2022
Indica Labs achieves CE-IVD certification for AI-based prostate cancer detection and Gleason grading tool
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
The HALO Prostate AI algorithm deployed in HALO AP from Indica Labs
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
As part of large-scale clinical studies prior to market introduction, the AI software has now gone into clinical test with patients, so-called first-in-human applications
Revolutionary ovarian cancer rapid test available Q4 2022
Vacuum-Assisted Breast Biopsy (VABB) is an innovative and more effective alternative to the traditional method where benign lumps are removed surgically, leaving scars and causing distress
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
BioFluidica LiquidScan harnesses the power of microfluidics
Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
Subscribe To Our Newsletter & Stay Updated
